trypan blue has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiruvella, KK; Hemlal, H; Joy, O; Moorthy, BT; Raghavan, SC; Ravi, S; Srivastava, M | 1 |
1 other study(ies) available for trypan blue and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Novel rhodanine derivatives induce growth inhibition followed by apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Coloring Agents; DNA Fragmentation; Dose-Response Relationship, Drug; Humans; L-Lactate Dehydrogenase; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Rhodanine; Tetrazolium Salts; Thiazoles; Trypan Blue | 2010 |